PolyPeptide Group AG (SWX: PPGN)

PolyPeptide Group AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	48.48	95.71	37.53	136.3	17.21	17.51
Cash & Short-Term Investments	48.48	95.71	37.53	136.3	17.21	17.51
Cash Growth	439.51%	155.03%	-72.47%	692.09%	-1.71%	74.43%
Accounts Receivable	59.14	78.78	49.15	67.79	55.54	35.45
Other Receivables	9.79	17.21	13.27	8.14	9.6	12.08
Receivables	68.93	95.98	62.41	75.92	65.14	47.53
Inventory	160.01	128.51	145.07	113	94.27	73.49
Prepaid Expenses	-	5.09	5	4.75	2.53	1.69
Other Current Assets	15.23	1.32	1.56	1.63	0.72	2.45
Total Current Assets	292.64	326.6	251.57	331.61	179.86	142.67
Property, Plant & Equipment	333.99	324.11	297.29	235.44	169.81	136.64
Long-Term Investments	6.24	5.24	2.77	3.47	0.2	0.46
Other Intangible Assets	16.47	16.45	15.87	14.27	12.56	12.31
Long-Term Deferred Tax Assets	15.63	16.69	8.29	10.26	13.55	13.07
Total Assets	664.97	689.09	575.78	595.04	375.98	305.14
Accounts Payable	41.58	60.91	45.93	28.48	28.36	18.46
Accrued Expenses	-	24.02	17.19	20.48	18.71	14.81
Short-Term Debt	41.22	41.25	-	-	-	-
Current Portion of Long-Term Debt	1.28	1.23	1.1	1.15	3.5	0.87
Current Portion of Leases	4.79	4.45	3.57	3.06	1.98	1.49
Current Income Taxes Payable	0.2	0.23	0.07	4	8.28	4.6
Current Unearned Revenue	67.78	42.97	27.54	46.13	34.07	10.39
Other Current Liabilities	26.75	1.39	0.66	0.67	6.96	7.32
Total Current Liabilities	183.61	176.45	96.05	103.96	101.85	57.94
Long-Term Debt	49.22	58.98	9.41	10.3	35.9	36.08
Long-Term Leases	19.3	18.87	17.65	14.95	10.45	8.87
Long-Term Unearned Revenue	20.25	23.16	-	-	-	-
Long-Term Deferred Tax Liabilities	2.96	3.64	1.88	1.11	0.88	1.12
Other Long-Term Liabilities	1.69	1.65	2.48	4.57	10.11	15.62
Total Liabilities	305.05	307.86	154.11	173.87	198.32	155.73
Common Stock	0.3	0.3	0.3	0.3	33	33
Additional Paid-In Capital	203.13	203.13	203.13	212.8	2.34	2.34
Retained Earnings	151.79	165.14	214.15	196.03	147.94	116.77
Treasury Stock	-9.37	-10.39	-13.61	-1.19	-	-
Comprehensive Income & Other	14.06	23.05	17.71	13.23	-5.62	-2.69
Shareholders' Equity	359.92	381.23	421.68	421.17	177.66	149.42
Total Liabilities & Equity	664.97	689.09	575.78	595.04	375.98	305.14
Total Debt	115.81	124.78	31.72	29.45	51.83	47.31
Net Cash (Debt)	-67.34	-29.08	5.8	106.85	-34.62	-29.8
Net Cash Growth	-	-	-94.57%	-	-	-
Net Cash Per Share	-2.06	-0.88	0.18	3.33	-1.15	-
Filing Date Shares Outstanding	32.98	32.97	32.93	33.1	30	-
Total Common Shares Outstanding	32.98	32.97	32.93	33.1	30	-
Working Capital	109.03	150.15	155.52	227.65	78.01	84.73
Book Value Per Share	10.91	11.56	12.81	12.72	5.92	-
Tangible Book Value	343.45	364.77	405.81	406.91	165.1	137.1
Tangible Book Value Per Share	10.41	11.06	12.33	12.29	5.50	-
Land	-	129.94	124.02	87.67	94.66	94.85
Machinery	-	243.43	201.16	170.55	138.83	124.76
Construction In Progress	-	91.17	98.64	87.4	49.57	22.09

Source: S&P Capital IQ. Standard template. Financial Sources.